Остеопороз и остеопатии

Расширенный поиск


Полный текст:


Об авторе

L. Alekseeva

Профессор, доктор медицинских наук, зав. лабораторией остеоартроза

Список литературы

1. Kadam U.N., Jordan K., Croft P.R. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales // Ann.Rheum.Dis 2004; 63: 408—14).

2. Zhang W., Moscovitz R.W., Nuki G., et al. OARSI recommendations for the menegement of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008 Feb; 16(2): 137—162].

3. McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469—75.

4. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005; (2): CD002946.

5. Herrero-Beaumont G., Ivorra J.A., Del Carmen Trabado M., et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007; 56: 555—67.

6. Leeb B.F., Schweitzer H., Montag K., Smolen J.S. A metaanalysis of chondroitinsulfate in the treatment of osteoarthritis. Osteoarthritis Cartilage, 1999, 7, Suppl A., abstr 130.

7. Bana G., Jamard B., Verrouil E., Mazieres B. Chondroitin sulfate in the management of hip and knee OA: an overview. Adv. Pharmacol., 2006, 53: 507—522.

8. Michel B.A., Stucki G., Frey D., et al. Chondroitin 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. Arthritis Rheum., 2005, 52 (3): 779—786.

9. Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010 Jun; 18 Suppl 1: S28—31.

10. Grading of Recommendations Assessment, Development and Evaluation) (Bruyère O., Burlet N., Delmas P., et al. Evaluation of Symptomatic Slow-Acting Drugs in Osteoarthritis Using the GRADE System. BMC Musculoskelet Disord (): , 2008.

11. Lippielo L., Woodword J., Karpman D. et al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr. Rheum., 1999; 42 (suppl.): S 256.

12. Leffler C.N., Phillipi A.F., Leffter S.G. et al. Glucosamine, chondroitin and magnaese ascorbate for degenerative joint disease of the knee or low back pain: a randomized, double-blind, placebocontrolled pilot study. Mil.Med 1999, 164: 85—91.

13. Das A.K., Hendsonville J., Eitel J., Hammad T. Efficacy of a new class of agents (Glucosamine Hydrochloride and Chondroitin Sulfate) in the treatment of osteoarthritis of the knee. 66th Ann Meeting of American Association of Hip and Knee Surgeons, Dallas, November 6-8, 1998, p.180

14. Clegg D.O., Reda D.J., Harris C.L et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006, 354 (8): 795—808.

15. M.C. Hochberg, R. D. Altman, K.T. April et al. American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care & Research Vol. 64, No. 4, April 2012, pp 465—474).


Для цитирования:

. ПРЕПАРАТЫ ЗАМЕДЛЕННОГО ДЕЙСТВИЯ В ЛЕЧЕНИИ ОСТЕОАРТРОЗА. Остеопороз и остеопатии. 2012;15(1):29-32.

For citation:

Alekseeva L.I. SYMPTOMATIC SLOW ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS. Osteoporosis and Bone Diseases. 2012;15(1):29-32. (In Russ.)

Просмотров: 578

ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)